Common Contracts

3 similar Underwriting Agreement contracts by La Jolla Pharmaceutical Co, Dyax Corp

8,695,653 Shares of Common Stock La Jolla Pharmaceutical Company Common Stock Underwriting Agreement
Underwriting Agreement • February 20th, 2004 • La Jolla Pharmaceutical Co • Biological products, (no disgnostic substances) • California

La Jolla Pharmaceutical Company, a Delaware corporation (the “Company”), proposes to issue and sell to you as the Underwriter (the “Underwriter”) an aggregate of 8,695,653 shares of Common Stock, $0.01 par value per share (the "Common Stock”), of the Company (the “Firm Shares”). In addition, solely for the purpose of covering over-allotments, the Company proposes to grant to the Underwriter the option to purchase from the Company up to an additional 1,304,347 shares of Common Stock (the “Option Shares”). The Firm Shares and the Option Shares (to the extent the aforementioned option is exercised) are herein collectively referred to as the “Offered Securities.”

5,220,000 Shares of Common Stock Dyax Corp. Common Stock Underwriting Agreement
Underwriting Agreement • December 31st, 2003 • Dyax Corp • Services-commercial physical & biological research • New York

Dyax Corp., a Delaware corporation (the “Company”), proposes to issue and sell to you as the Underwriter (the “Underwriter”) an aggregate of 5,220,000 shares of Common Stock, $0.01 par value per share (the “Common Stock”), of the Company the “Firm Shares”). In addition, solely for the purpose of covering over-allotments, the Company proposes to grant to the Underwriter the option to purchase from the Company up to an additional 780,000 shares of Common Stock (the “Option Shares”). The Firm Shares and the Option Shares (to the extent the aforementioned option is exercised) are herein collectively referred to as the “Offered Securities.”

8,150,000 Shares of Common Stock La Jolla Pharmaceutical Company Common Stock Underwriting Agreement
Underwriting Agreement • August 12th, 2003 • La Jolla Pharmaceutical Co • Biological products, (no disgnostic substances) • California

La Jolla Pharmaceutical Company, a Delaware corporation (the “Company”), proposes to issue and sell to you as the Underwriter (the “Underwriter”) an aggregate of 8,150,000 shares of Common Stock, $0.01 par value per share (the “Common Stock”), of the Company (the “Offered Securities”).